GATA-3 Links Tumor Differentiation and Dissemination in a Luminal Breast Cancer Model: Cancer Cell
ZNF503/Zpo2 drives aggressive breast cancer progression by down-regulation of GATA3 expression. - Abstract - Europe PMC
Combination of GATA3, SOX-10, and PAX8 in a Comprehensive Panel to Diagnose Breast Cancer Metastases | In Vivo
GATA3 is downregulated in HCC and accelerates HCC aggressiveness by transcriptionally inhibiting slug expression Corrigendum in /10.3892/ol.2021.12836
Expression of GATA3 in MDA-MB-231 Triple-negative Breast Cancer Cells Induces a Growth Inhibitory Response to TGFß | PLOS ONE
Anti-GATA-3 Monoclonal Antibody(Clone: GATA3/2444)
Expression of GATA3 in breast cancer cells before and after... | Download Scientific Diagram
Notch3 expression is associated with GATA-3 in breast cancer clinical... | Download Scientific Diagram
Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapy - Annals of Oncology
Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapy - ScienceDirect
GATA3 (MSVA-450M) - MS Validated Antibodies
GeneAb™ GATA3 - Attogene
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers | bioRxiv
14-3-3τ drives estrogen receptor loss via ERα36 induction and GATA3 inhibition in breast cancer | PNAS
Q&A column - CAP TODAY
GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. - Abstract - Europe PMC
Pathology Outlines - GATA3
Anti-GATA-3 Monoclonal Antibody(Clone: GATA3/2442)
Expression of GATA3 in MDA-MB-231 Triple-negative Breast Cancer Cells Induces a Growth Inhibitory Response to TGFß | PLOS ONE
The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver | Oncogene
Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer - ScienceDirect
